Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.20
Bid: 135.00
Ask: 135.60
Change: -0.80 (-0.59%)
Spread: 0.60 (0.444%)
Open: 135.00
High: 136.00
Low: 133.20
Prev. Close: 134.20
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

30 Mar 2020 07:01

RNS Number : 9565H
Kier Group PLC
30 March 2020
 

Kier Group plc

Board Changes

Kier Group plc (the "Company" or the "Group") announces the appointments of Mr. Clive Watson and Dame Heather Rabbatts to its board of directors (the "Board") with immediate effect.

Clive Watson is currently a non-executive director of Breedon Group plc and discoverIE Group plc, where he is the Chair of the Audit and Risk Committee, having previously been a non-executive director of Spirax-Sarco Engineering plc, where he was the Senior Independent Director and the Chair of the Audit Committee. During his executive career, Clive was the Group Finance Director at Spectris plc from 2006-2019, having previously held a number of senior finance positions at Borealis, Thorn Lighting Group and The Black & Decker Corporation.

Clive will be the Chair of the Risk Management and Audit Committee and a member of the Nomination Committee, the Remuneration Committee and the Safety, Health and Environment Committee.

Justin Atkinson will stand down from the role of acting Chair of the Risk Management and Audit Committee with immediate effect and continue in the role of Senior Independent Director.

Heather Rabbatts has held a number of executive and non-executive positions in the local government, entertainment and sport sectors, in particular. Heather is currently the Chair of Soho Theatre Company and her recent non-executive directorships include Crossrail, the Football Association, where she was a member of the Remuneration Committee, and Grosvenor Britain & Ireland, where she was the Chair of the Audit Committee.

Heather will be the Chair of the Remuneration Committee and a member of the Nomination Committee, the Risk Management and Audit Committee and the Safety, Health and Environment Committee.

Constance Baroudel, the current Chair of the Remuneration Committee, will stand down from the Board with immediate effect.

Matthew Lester, Chairman, said: "We are delighted that Clive and Heather will be joining the Board. Both have a depth of experience which will be invaluable as the Board continues to oversee the delivery of the Group's strategic objectives. I look forward to working with Clive and Heather.

I would like to thank Constance for her contribution over almost four years on the Board. I would also like to thank Justin for undertaking the role of Chair of the Risk Management and Audit Committee on an interim basis.

As the Chair of the Remuneration Committee, Heather will be engaging with shareholders with respect to the Company's revised remuneration policy, which will assist her to understand the reasons for the significant vote against the Directors' Remuneration Report at the 2019 AGM and to consider any actions which may need to be taken as a result."

In relation to the appointment of Clive Watson, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

In relation to the appointment of Heather Rabbatts, no information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Further information

Please contact:

 

Kier Press Office 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI Consulting 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMZGZFRLKGGZM
Date   Source Headline
16th Sep 20217:00 amRNSResults for the year ended 30 June 2021
9th Sep 202111:00 amRNSHolding(s) in Company
2nd Sep 202111:22 amRNSHolding(s) in Company
1st Sep 20218:52 amRNSTotal Voting Rights
31st Aug 20214:07 pmRNSHolding(s) in Company
23rd Aug 20211:05 pmRNSHolding(s) in Company
20th Aug 202110:27 amRNSDirector/PDMR Shareholding
2nd Aug 20219:27 amRNSTotal Voting Rights
23rd Jul 202111:46 amRNSDirector/PDMR Shareholding
23rd Jul 20219:36 amRNSHolding(s) in Company
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
1st Jul 20219:05 amRNSBlock listing Interim Review
1st Jul 20218:36 amRNSTotal Voting Rights
25th Jun 20214:41 pmRNSHolding(s) in Company
22nd Jun 20214:05 pmRNSHolding(s) in Company
21st Jun 20213:59 pmRNSDirector/PDMR Shareholding
21st Jun 20212:59 pmRNSHolding(s) in Company
18th Jun 20212:30 pmRNSDirector/PDMR Shareholding
18th Jun 20219:47 amRNSDirector/PDMR Shareholding
18th Jun 20218:30 amRNSHolding(s) in Company
18th Jun 20217:00 amRNSAdmission to trading and notice of trading update
17th Jun 20214:07 pmRNSHolding(s) in Company
16th Jun 202110:17 amRNSResult of Meeting
15th Jun 20218:11 amRNSResult of Open Offer
28th May 20212:56 pmRNSCompletion of the sale of Kier Living
14th May 20214:30 pmRNSDirector/PDMR Shareholding
13th May 20215:36 pmRNSPublication of Prospectus and Notice of GM
13th May 20213:34 pmRNSSuccessful completion of Accelerated Bookbuild
13th May 20217:00 amRNSProposed c.£241 million Capital Raise
7th May 202110:29 amRNSResult of Meeting
5th May 20217:00 amRNSExecutive Appointments
21st Apr 20217:00 amRNSResults for the six months ended 31 December 2020
20th Apr 20215:02 pmRNSNotice of GM
16th Apr 20215:01 pmRNSSale of Kier Living
12th Apr 202111:52 amRNSDirector/PDMR Shareholding
19th Mar 20213:07 pmRNSDirector/PDMR Shareholding
22nd Feb 20214:37 pmRNSDirector/PDMR Shareholding
16th Feb 20216:15 pmRNSDirector Declaration
1st Feb 20217:17 amRNSDirector Declaration
19th Jan 20212:12 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSTrading update
13th Jan 20219:04 amRNSBlock listing Interim Review
21st Dec 202012:32 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 202010:53 amRNSResult of AGM
17th Dec 20207:00 amRNS2020 Annual General Meeting
24th Nov 202010:19 amRNSHolding(s) in Company
19th Nov 20202:06 pmRNSDirector/PDMR Shareholding
27th Oct 20209:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.